# EDGAR Filing Document

**Accession Number:** 0001314052
**File Stem:** 0001731122-25-001001
**Filing Date:** 2025-7
**Character Count:** 2144
**Document Hash:** b036fc9f6c629d759f35d3b6b614a2b5
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001731122-25-001001.hdr.sgml**: 20250820

**ACCESSION NUMBER**: 0001731122-25-001001

**CONFORMED SUBMISSION TYPE**: CORRESP

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20250721

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ANAVEX LIFE SCIENCES CORP.
- **CENTRAL INDEX KEY:** 0001314052
- **STANDARD INDUSTRIAL CLASSIFICATION:** BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
- **ORGANIZATION NAME:** 03 Life Sciences
- **EIN:** 980608404
- **FISCAL YEAR END:** 0930

**FILING VALUES:**
- **FORM TYPE:** CORRESP

**BUSINESS ADDRESS:**
- **STREET 1:** 630 5TH AVENUE
- **STREET 2:** 20TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10111
- **BUSINESS PHONE:** 844-689-3939

**MAIL ADDRESS:**
- **STREET 1:** 630 5TH AVENUE
- **STREET 2:** 20TH FLOOR
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10111

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** Thrifty Printing Inc.
- **DATE OF NAME CHANGE:** 20050111

**ANAVEX LIFE SCIENCES CORP.<br> 630 5th Avenue, 20th Floor** 

**New York, NY USA 10111**

July 21, 2025

**VIA EDGAR**

United States Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549

Attn: Jessica Dickerson

---

| | |
|:---|:---|
| **Re:** | **Anavex Life Sciences Corp.** |
|  | **Request for Acceleration of Registration Statement on Form S-3** |
|  | **File No. 333-288661** |

---

Ladies and Gentlemen:

Pursuant to Rule 461 under the Securities Act of 1933, as amended, Anavex Life Sciences Corp., a Nevada corporation (the "<u>Company</u>"), hereby requests acceleration of the effectiveness of its Registration Statement on Form S-3 (File No. 333-288661), filed with the U.S. Securities and Exchange Commission on July 14, 2025, to 4:00 P.M. ET on July 23, 2025 or as soon thereafter as practicable.

Please direct any questions or comments regarding this filing to Clayton Parker, Esq. at (305) 794-6293 or Clayton.Parker@klgates.com of K&L Gates LLP, legal counsel to the Company.

---

| |
|:---|
| Sincerely, |
| *<u>/s/ Christopher Missling, PhD</u>* |
| Christopher Missling, PhD <br> Chief Executive Officer |

---